Role of tumor necrosis factor-α and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma

Cancer Research

Volumn 67, Issue 24, 2007, Pages 11811-11820

  Shareef, Mohammed M ^a   Cui, Nuan ^b   Burikhanov, Ravshan ^b   Gupta, Seema ^a   Satishkumar, Sabapathi ^b   Shajahan, Shahin ^b,d   Mohiuddin, Mohammed ^c   Rangnekar, Vivek M ^b   Ahmed, Mansoor M ^a,c  

^a WEIS CENTER FOR RESEARCH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; NEUTRALIZING ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 4; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER CELL CULTURE; CELL NUCLEUS; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN SECRETION; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BYSTANDER EFFECT; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; EARLY GROWTH RESPONSE PROTEIN 1; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; X-RAYS;

EID: 37549009969     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0722     Document Type: Article

References (50)

1. Olive PL. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat Res 1998;150:S42-51.
2. Little JB. Genomic instability and bystander effects: a historical perspective. Oncogene 2003;22:6978-87.
3. Mothersill C, Seymour C. Radiation-induced bystander and other non-targeted effects: novel intervention points in cancer therapy? Curr Cancer Drug Targets 2006;6:447-54.
4. Morgan WF, Sowa MB. Non-targeted bystander effects induced by ionizing radiation. Mutat Res 2007;616:159-64.
5. Hall EJ. The bystander effect. Health Phys 2003;85:31-5.
6. Snyder AR. Review of radiation-induced bystander effects. Hum Exp Toxicol 2004;23:87-9.
7. Sawant SG, Zheng W, Hopkins KM, Randers-Pehrson G, Lieberman HB, Hall EJ. The radiation-induced bystander effect for clonogenic survival. Radiat Res 2002;157:361-4.
8. Datta R, Taneja N, Su khatme VP, Qu r eshi SA, Weichselbaum R, Kufe DW. Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci U S A 1993;90:2419-22.
9. Ahmed MM. Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. Curr Cancer Drug Targets 2004;4:43-52.
10. Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, Weichselbaum RR. Protein kinase C mediates X-ray inducibility of nuclear signal transducers EGR-1 and JUN. Proc Natl Acad Sci U S A 1991;88:2156-60.
11. Ahmed MM, Sells SF, Venkatasubbarao K, et al. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem 1997;272:33056-61.
12. Kramer B, Meichle A, Hensel G, Charnay P, Kronke M. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim Biophys Acta 1994;1219:413-21.
13. Unnithan J, Macklis RM. TRAIL induction by radiation in lymphoma patients. Cancer Invest 2004;22:522-5.
14. Gong B, Almasan A. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res 2000;60:5754-60.
15. Kagawa S, He C, Gu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001;61:3330-8.
16. -/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis. J Biol Chem 2001;276:3279-86.
17. Russo MW, Sevetson BR, Milbrandt J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci U S A 1995;92:6873-7.
18. Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 1996;16:3545-53.
19. Sathishkumar S, Dey S, Meigooni AS, et al. The impact of TNF-α induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol Cancer Res Treat 2002;1:141-7.
20. Orlando V, Strutt H, Paro R. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 1997;11:205-14.
21. Sak A, Wurm R, Elo B, et al. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1). Cancer Gene Ther 2003;10:926-34.
22. Fu XY, Zhang SW, Ran RQ, Shen ZH, Gu JX, Cao SL. Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines. J Cancer Res Clin Oncol 1998;124:621-6.
23. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-82.
24. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;271:12687-90.
25. Ito CY, Kazantsev AG, Baldwin AS, Jr. Three NF-κ B sites in the I κ B-α promoter are required for induction of gene expression by TNF α. Nucleic Acids Res 1994;22:3787-92.
26. Sells SF, Wood DP, Jr., Joshi-Barve SS, et al. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 1994;5:457-66.
27. El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol Cell Biol 2003;23:5516-25.
28. Boehrer S, Nowak D, Puccetti E, et al. Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis. Leuk Res 2006;30:597-605.
29. Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 1998;28:973-82.
30. Muthukkumar S, Nair P, Sells SF, Maddiwar NG, Jacob RJ, Rangnekar VM. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-6. Mol Cell Biol 1995;15:6262-72.
31. Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP, Rangnekar VM. Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem 1997;272:20131-8.
32. Nikjoo H, Khvostunov IK. Biophysical model of the radiation-induced bystander effect. Int J Radiat Biol 2003;79:43-52.
33. Mohiuddin M, Curtis DL, Grizos WT, Komarnicky L. Palliative treatment of advanced cancer using multiple nonconfluent pencil beam radiation. A pilot study. Cancer 1990;66:114-8.
34. Mohiuddin M, Fujita M, Regine WF, Megooni AS, Ibbott GS, Ahmed MM. High-dose spatially-fractionated radiation (GRID): a new paradigm in the management of advanced cancers. Int J Radiat Oncol Biol Phys 1999;45:721-7.
35. Reiff JE, Huq MS, Mohiuddin M, Suntharalingam N. Dosimetric properties of megavoltage grid therapy. Int J Radiat Oncol Biol Phys 1995;33:937-42.
36. Meigooni AS, Parker SA, Zheng J, Kalbaugh KJ, Regine WF, Mohiuddin M. Dosimetric characteristics with spatial fractionation using electron grid therapy. Med Dosim 2002;27:37-42.
37. Zwicker RD, Meigooni A, Mohiuddin M. Therapeutic advantage of grid irradiation for large single fractions. Int J Radiat Oncol Biol Phys 2004;58:1309-15.
38. Sathishkumar S, Boyanovsky B, Karakashian AA, et al. Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol Ther 2005;4:979-86.
39. Bowler DA, Moore SR, Macdonald DA, Smyth SH, Clapham P, Kadhim MA. Bystander-mediated genomic instability after high LET radiation in murine primary haemopoietic stem cells. Mutat Res 2006;597:50-61.
40. Iyer R, Lehnert BE. Low dose, low-LET ionizing radiation-induced radioadaptation and associated early responses in unirradiated cells. Mutat Res 2002;503:1-9.
41. Yang H, Asaad N, Held KD. Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts. Oncogene 2005;24:2096-103.
42. Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004;14:433-9.
43. de Jong S, Timmer T, Heijenbrok FJ, de Vries EG. Death receptor ligands, in particular TRAIL, to overcome drug resistance. Cancer Metastasis Rev 2001;20:51-6.
44. Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003;14:337-48.
45. Wajant H. TRAIL and NFκB signaling-a complex relationship. Vitam Horm 2004;67:101-32.
46. Wajant H, Moosmayer D, Wuest T, et al. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene 2001;20:4101-6.
47. Falschlehner C, Emmerich CH, Gerlach B, Walczak H. TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 2007.
48. Won J, Kim DY, La M, Kim D, Meadows GG, Joe CO. Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. J Biol Chem 2003;278:19347-51.
49. Goswami A, Burikhanov R, de Thonel A, et al. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol Cell 2005;20:33-44.
50. Datta R, Rubin E, Sukhatme V, et al. Ionizing radiation activates transcription of the EGR-1 gene via CArG elements. Proc Natl Acad Sci U S A 1992;89:10149-53.